What are the normal serum alpha‑fetoprotein (AFP) ranges for infants expressed in ng/mL?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Normal Serum Alpha-Fetoprotein Ranges in Infants

For term infants at birth, normal serum AFP levels are approximately 15,700-146,500 ng/mL (95% CI), with a median of 48,300 ng/mL, declining rapidly in the first weeks of life to reach 9,700-111,900 ng/mL by hospital discharge around 60 hours of age 1.

Age-Specific Reference Ranges

At Birth

  • Term infants (≥37 weeks): Mean 41,687 ng/mL 2
  • Near-term infants (≥34 weeks): 15,700-146,500 ng/mL (95% CI), median 48,300 ng/mL 1
  • Premature infants (<37 weeks): Mean 158,125 ng/mL 2

Critical caveat: AFP levels are inversely correlated with gestational age—the more premature the infant, the higher the AFP level 1.

First Weeks of Life

  • Half-life in term infants: 5.1 days during the first 4 weeks 2
  • At hospital discharge (60±24 hours): 9,700-111,900 ng/mL (95% CI), median 34,200 ng/mL 1

6 Months to 2 Years

  • Day 180-720 of life: Up to 87 ng/mL (95.5% interval), mean 8 ng/mL 2
  • By age 2 years: Infants have NOT yet reached adult levels (0-6 ng/mL) 2

Clinical Interpretation Considerations

The most important pitfall is failing to account for the steep decline in AFP during early infancy. Using discrete age partitions can lead to false-positive interpretations, particularly in the first 3 months of life 3. The most recent high-quality evidence from 2026 demonstrates that continuous age-specific reference intervals provide superior clinical interpretation compared to discrete partitions during this period 3.

Key Modifying Factors

  • Gestational age: Significant negative correlation—premature infants have approximately 3.8-fold higher levels than term infants 2, 1
  • Birthweight: Lesser but significant negative correlation 1
  • Sex: No significant differences between males and females 1
  • Body weight: Not independently associated with AFP after age adjustment 3

For Extremely Low Birthweight Infants (<1000g)

A specific regression formula applies 4:

  • log₁₀(AFP [ng/mL]) = 11.063 - 3.752 log₁₀(age [days])
  • This provides the 95% CI for ELBWI up to 2 years after birth

Practical Application

When evaluating AFP in infants, always reference age-specific values rather than adult ranges. For infants 0-3 years, consider using continuous reference intervals with daily resolution for 0-90 days and monthly resolution for 4-12 months 3. For tumor marker surveillance (hepatoblastoma, yolk sac tumors), serial measurements tracking the half-life decline are more informative than single values 5.

The wide standard deviations in all studies necessitate caution when interpreting individual values near reference limits—median values are more clinically useful than means due to the non-normal distribution 1.

References

Research

Alpha-fetoprotein in the early neonatal period--a large study and review of the literature.

Clinica chimica acta; international journal of clinical chemistry, 2004

Research

Serum α-fetoprotein concentration in extremely low-birthweight infants.

Pediatrics international : official journal of the Japan Pediatric Society, 2017

Research

Alpha-fetoprotein (AFP) levels in normal children.

European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie, 1997

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.